Christopher R. Fenimore - 08 Dec 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
SVP Controller
Signature
/s/**Christopher R. Fenimore
Issuer symbol
REGN
Transactions as of
08 Dec 2021
Net transactions value
$0
Form type
4
Filing time
10 Dec 2021, 16:28:50 UTC
Previous filing
25 Aug 2021
Next filing
14 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Award $0 +1,859 +9.5% $0.000000 21,392 08 Dec 2021 Direct F1
holding REGN Common Stock 2,082 08 Dec 2021 2021 GRAT
holding REGN Common Stock 1,459 08 Dec 2021 By 401(k) Plan
holding REGN Common Stock 1,897 08 Dec 2021 By Trust F2
holding REGN Common Stock 1,348 08 Dec 2021 by 2018 GRAT
holding REGN Common Stock 25 08 Dec 2021 by Trust for Daugh
holding REGN Common Stock 25 08 Dec 2021 by Trust for Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Award $0 +7,941 $0.000000 7,941 08 Dec 2021 Common Stock 7,941 $644.54 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.
F2 These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
F3 The stock option award vests in four equal annual installments, commencing one year after the date of grant.